Moderna has paused its mRNA RSV (Respiratory Syncytial Virus) vaccine trial for children after five infants were hospitalized with severe respiratory complications.
This comes just days after the FDA quietly admitted it had halted enrollment in similar trials, citing safety concerns for children under two years old.
Complete Article
www.thegatewaypundit.com
This comes just days after the FDA quietly admitted it had halted enrollment in similar trials, citing safety concerns for children under two years old.
Complete Article

Moderna Halts mRNA RSV Vaccine Trial for Children After Five Infants were Hospitalized | The Gateway Pundit | by Jim Hᴏft
Moderna's recent decision to pause its mRNA RSV vaccine trial for children raises critical safety concerns. Explore the implications of this development and potential risks associated with mRNA technology.
